Report Detail
Global Interleukin 17A Market Insights, Forecast to 2025
- RnM2896934 |
- 07 February, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
The global Interleukin 17A market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Interleukin 17A market based on company, product type, end user and key regions.
This report studies the global market size of Interleukin 17A in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Interleukin 17A in these regions.
This research report categorizes the global Interleukin 17A market by top players/brands, region, type and end user. This report also studies the global Interleukin 17A market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Market size by Product
ABY-035
CNTO-6785
DLX-2882
Others
Market size by End User
Chronic Pain
Liver Cancer
Kidney Cancer
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Interleukin 17A market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Interleukin 17A market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Interleukin 17A companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Interleukin 17A submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Interleukin 17A are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Interleukin 17A market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Interleukin 17A Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Interleukin 17A Market Size Growth Rate by Product
- 1.4.2 ABY-035
- 1.4.3 CNTO-6785
- 1.4.4 DLX-2882
- 1.4.5 Others
- 1.5 Market by End User
- 1.5.1 Global Interleukin 17A Market Size Growth Rate by End User
- 1.5.2 Chronic Pain
- 1.5.3 Liver Cancer
- 1.5.4 Kidney Cancer
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Interleukin 17A Market Size
- 2.1.1 Global Interleukin 17A Revenue 2014-2025
- 2.1.2 Global Interleukin 17A Sales 2014-2025
- 2.2 Interleukin 17A Growth Rate by Regions
- 2.2.1 Global Interleukin 17A Sales by Regions
- 2.2.2 Global Interleukin 17A Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Interleukin 17A Sales by Manufacturers
- 3.1.1 Interleukin 17A Sales by Manufacturers
- 3.1.2 Interleukin 17A Sales Market Share by Manufacturers
- 3.1.3 Global Interleukin 17A Market Concentration Ratio (CR5 and HHI)
- 3.2 Interleukin 17A Revenue by Manufacturers
- 3.2.1 Interleukin 17A Revenue by Manufacturers (2014-2019)
- 3.2.2 Interleukin 17A Revenue Share by Manufacturers (2014-2019)
- 3.3 Interleukin 17A Price by Manufacturers
- 3.4 Interleukin 17A Manufacturing Base Distribution, Product Types
- 3.4.1 Interleukin 17A Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Interleukin 17A Product Type
- 3.4.3 Date of International Manufacturers Enter into Interleukin 17A Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Interleukin 17A Sales by Product
- 4.2 Global Interleukin 17A Revenue by Product
- 4.3 Interleukin 17A Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Interleukin 17A Breakdown Data by End User
6 North America
- 6.1 North America Interleukin 17A by Countries
- 6.1.1 North America Interleukin 17A Sales by Countries
- 6.1.2 North America Interleukin 17A Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Interleukin 17A by Product
- 6.3 North America Interleukin 17A by End User
7 Europe
- 7.1 Europe Interleukin 17A by Countries
- 7.1.1 Europe Interleukin 17A Sales by Countries
- 7.1.2 Europe Interleukin 17A Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Interleukin 17A by Product
- 7.3 Europe Interleukin 17A by End User
8 Asia Pacific
- 8.1 Asia Pacific Interleukin 17A by Countries
- 8.1.1 Asia Pacific Interleukin 17A Sales by Countries
- 8.1.2 Asia Pacific Interleukin 17A Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Interleukin 17A by Product
- 8.3 Asia Pacific Interleukin 17A by End User
9 Central & South America
- 9.1 Central & South America Interleukin 17A by Countries
- 9.1.1 Central & South America Interleukin 17A Sales by Countries
- 9.1.2 Central & South America Interleukin 17A Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Interleukin 17A by Product
- 9.3 Central & South America Interleukin 17A by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Interleukin 17A by Countries
- 10.1.1 Middle East and Africa Interleukin 17A Sales by Countries
- 10.1.2 Middle East and Africa Interleukin 17A Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Interleukin 17A by Product
- 10.3 Middle East and Africa Interleukin 17A by End User
11 Company Profiles
- 11.1 AbbVie Inc
- 11.1.1 AbbVie Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AbbVie Inc Interleukin 17A Products Offered
- 11.1.5 AbbVie Inc Recent Development
- 11.2 Abeome Corporation
- 11.2.1 Abeome Corporation Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Abeome Corporation Interleukin 17A Products Offered
- 11.2.5 Abeome Corporation Recent Development
- 11.3 Affibody AB
- 11.3.1 Affibody AB Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Affibody AB Interleukin 17A Products Offered
- 11.3.5 Affibody AB Recent Development
- 11.4 Cell Medica Limited
- 11.4.1 Cell Medica Limited Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Cell Medica Limited Interleukin 17A Products Offered
- 11.4.5 Cell Medica Limited Recent Development
- 11.5 Eli Lilly and Company
- 11.5.1 Eli Lilly and Company Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Eli Lilly and Company Interleukin 17A Products Offered
- 11.5.5 Eli Lilly and Company Recent Development
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Johnson & Johnson Interleukin 17A Products Offered
- 11.6.5 Johnson & Johnson Recent Development
- 11.7 Merck KGaA
- 11.7.1 Merck KGaA Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck KGaA Interleukin 17A Products Offered
- 11.7.5 Merck KGaA Recent Development
- 11.8 Novartis AG
- 11.8.1 Novartis AG Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Novartis AG Interleukin 17A Products Offered
- 11.8.5 Novartis AG Recent Development
- 11.9 Orega Biotech SAS
- 11.9.1 Orega Biotech SAS Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Orega Biotech SAS Interleukin 17A Products Offered
- 11.9.5 Orega Biotech SAS Recent Development
12 Future Forecast
- 12.1 Interleukin 17A Market Forecast by Regions
- 12.1.1 Global Interleukin 17A Sales Forecast by Regions 2019-2025
- 12.1.2 Global Interleukin 17A Revenue Forecast by Regions 2019-2025
- 12.2 Interleukin 17A Market Forecast by Product
- 12.2.1 Global Interleukin 17A Sales Forecast by Product 2019-2025
- 12.2.2 Global Interleukin 17A Revenue Forecast by Product 2019-2025
- 12.3 Interleukin 17A Market Forecast by End User
- 12.4 North America Interleukin 17A Forecast
- 12.5 Europe Interleukin 17A Forecast
- 12.6 Asia Pacific Interleukin 17A Forecast
- 12.7 Central & South America Interleukin 17A Forecast
- 12.8 Middle East and Africa Interleukin 17A Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Interleukin 17A Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Interleukin 17A . Industry analysis & Market Report on Interleukin 17A is a syndicated market report, published as Global Interleukin 17A Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Interleukin 17A market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
